Avalo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.About AVTX
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders.
CEOGarry Arthur Neil
CEOGarry Arthur Neil
Employees23
Employees23
HeadquartersWayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded2011
Founded2011
Employees23
Employees23
AVTX Key Statistics
Market cap321.52M
Market cap321.52M
Price-Earnings ratio-2.03
Price-Earnings ratio-2.03
Dividend yield—
Dividend yield—
Average volume297.36K
Average volume297.36K
High today$20.28
High today$20.28
Low today$17.62
Low today$17.62
Open price$18.61
Open price$18.61
Volume143.00K
Volume143.00K
52 Week high$20.72
52 Week high$20.72
52 Week low$3.39
52 Week low$3.39
Stock Snapshot
The current Avalo Therapeutics(AVTX) stock price is $17.70, with a market capitalization of 321.52M. The stock trades at a price-to-earnings (P/E) ratio of -2.03.
As of 2025-12-16, Avalo Therapeutics(AVTX) stock has fluctuated between $17.62 and $20.28. The current price stands at $17.70, placing the stock +0.5% above today's low and -12.7% off the high.
Avalo Therapeutics(AVTX) shares are trading with a volume of 143K, against a daily average of 297.36K.
In the last year, Avalo Therapeutics(AVTX) shares hit a 52-week high of $20.72 and a 52-week low of $3.39.
In the last year, Avalo Therapeutics(AVTX) shares hit a 52-week high of $20.72 and a 52-week low of $3.39.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AVTX. This list is generated using Robinhood data, and it’s not a recommendation.